Swiss National Bank
RLAY icon

Swiss National Bank’s Relay Therapeutics RLAY Stock Holding History

Swiss National Bank’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.43M Sell
236,600
-1,400
-0.6% -$20.3K ﹤0.01% 1513
2026
Q1 		$2.37M Hold
238,000
– – ﹤0.01% 1763
2025
Q4 		$2.01M Buy
238,000
+5,300
+2% +$37.8K ﹤0.01% 1865
2025
Q3 		$1.21M Buy
232,700
+5,700
+3% +$21.7K ﹤0.01% 2082
2025
Q2 		$785K Hold
227,000
– – ﹤0.01% 2231
2025
Q1 		$595K Buy
227,000
+7,400
+3% +$29K ﹤0.01% 2313
2024
Q4 		$905K Hold
219,600
– – ﹤0.01% 2247
2024
Q3 		$1.55M Buy
219,600
+51,800
+31% +$387K ﹤0.01% 1996
2024
Q2 		$1.09M Buy
167,800
+4,300
+3% +$29.4K ﹤0.01% 2134
2024
Q1 		$1.36M Buy
163,500
+7,100
+5% +$69.3K ﹤0.01% 2062
2023
Q4 		$1.72M Sell
156,400
-17,400
-10% -$147K ﹤0.01% 1932
2023
Q3 		$1.46M Buy
173,800
+2,000
+1% +$21.5K ﹤0.01% 2024
2023
Q2 		$2.16M Buy
171,800
+2,100
+1% +$26.1K ﹤0.01% 1836
2023
Q1 		$2.79M Sell
169,700
-19,000
-10% -$341K ﹤0.01% 1628
2022
Q4 		$2.82M Buy
188,700
+3,800
+2% +$72.7K ﹤0.01% 1667
2022
Q3 		$4.14M Buy
184,900
+31,900
+21% +$700K ﹤0.01% 1388
2022
Q2 		$2.56M Buy
153,000
+50,800
+50% +$1.09M ﹤0.01% 1743
2022
Q1 		$3.06M Buy
102,200
+8,800
+9% +$214K ﹤0.01% 1769
2021
Q4 		$2.87M Buy
93,400
+21,900
+31% +$692K ﹤0.01% 1817
2021
Q3 		$2.25M Buy
71,500
+1,800
+3% +$60.6K ﹤0.01% 1981
2021
Q2 		$2.55M Buy
69,700
+8,000
+13% +$264K ﹤0.01% 1946
2021
Q1 		$2.13M Buy
61,700
+700
+1% +$30.4K ﹤0.01% 1962
2020
Q4 		$2.54M Buy
+61,000
New +$2.76M ﹤0.01% 1777

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Swiss National Bank's RLAY Position: Q2 2026 in Review

Swiss National Bank reduced its Relay Therapeutics (RLAY) stake by 0.59% in Q2 2026, selling an estimated $20.3K and leaving 236,600 shares worth $4.43M. The position accounts for ﹤0.01% of the portfolio, ranked #1513.

Swiss National Bank first reported a position in RLAY in Q4 2020 and has held it in 23 quarters since. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Swiss National Bank held 236,600 shares of Relay Therapeutics worth $4.43M as of Q2 2026.
  • Swiss National Bank sold 1,400 Relay Therapeutics shares in Q2 2026, an estimated $20.3K.
  • Relay Therapeutics made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #1513 holding.
  • Swiss National Bank first reported a position in Relay Therapeutics in Q4 2020 and has held it in 23 quarters since.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.